Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.

Item
http://www.wikidata.org/entity/Q34497119
Therapeutic radionuclides in nuclear medicine: current and future prospectsLow-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.Have we overestimated the benefit of human(ized) antibodies?Novel monoclonal antibodies for cancer treatment: the trifunctional antibody catumaxomab (removab).Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascitesLong-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphomaYttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.Immunotherapeutic approaches in prion disease: progress, challenges and potential directions.Identification of two aberrant transcripts derived from a hybridoma with amplification of functional immunoglobulin variable genes.A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study.Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.Transient human anti-mouse antibody generated with immune enhancement in a carbohydrate antigen 19-9 immunoassay after surgical resection of recurrent cancer.
P2860

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.

Item
http://www.wikidata.org/entity/Q34497119
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Survival benefit associated wi ...... ents with B-cell malignancies.
@ast
Survival benefit associated wi ...... ents with B-cell malignancies.
@en
Survival benefit associated with human anti-mouse antibody
@nl
type
label
Survival benefit associated wi ...... ents with B-cell malignancies.
@ast
Survival benefit associated wi ...... ents with B-cell malignancies.
@en
Survival benefit associated with human anti-mouse antibody
@nl
prefLabel
Survival benefit associated wi ...... ents with B-cell malignancies.
@ast
Survival benefit associated wi ...... ents with B-cell malignancies.
@en
Survival benefit associated with human anti-mouse antibody
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Survival benefit associated wi ...... ents with B-cell malignancies.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921